A recent longitudinal cohort study shows a statistically significant relationship between body image disturbance, pain, and persistent depression in patients with Cushing syndrome.

On the occasion of Rare Disease Day, the Biofisika Institute (CSIC, EHU) presents the progress of a project aimed at understanding the molecular origin of CTNNB1 neurodevelopmental syndrome, a rare ...

Crinetics Pharmaceuticals (NASDAQ:CRNX) executives highlighted early commercial momentum for PALSONIFY, outlined a global phase II/III study plan for atumelnant in ACTH-dependent Cushing’s syndrome ...

We're transitioning from building a pipeline to building a business." He highlighted the successful launch of PALSONIFY as the company's first commercial product and emphasized its label reflecting ...

Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December ...

Q4 2025 earnings call: 2026 revenue guidance $900M–$1B, FDA relacorilant setback, ROSELLA win, generic risks—read now.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Amy Schumer has lost a considerable amount of weight over the past few months—over 50 pounds to date—and says that her weight loss journey was brought on by her Cushing Syndrome diagnosis, saying she ...

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The same drug is under FDA ...

Amy Schumer is clearing up speculation over her recent 50-pound weight loss. The comedian stated in a social media post that she didn't undergo the transformation "to look hot, which does feel fun and ...